Document:

<PAGE>
                                                                   EXHIBIT 10.93

        SUMMARY OF BOARD OF DIRECTORS COMPENSATION (AS OF MARCH 22, 2004)

         Below is a summary of compensation received for service on the Andrx
Board of Directors and its committees by Andrx's non-management directors, other
than Elliot Hahn, Ph.D. Dr. Hahn's compensation for service to the Board of
Directors can be found in Exhibit 10.86 to Andrx's Form 8-K filed November 18,
2004.

DIRECTOR COMPENSATION

         Directors who are current employees of Andrx do not receive any cash
compensation for their services as a director, as they are instead compensated
as Andrx employees. Directors who are former Andrx employees that were granted
stock options as employees do not receive any cash compensation or stock options
for their service as a director, while the options they received as an Andrx
employee continue to vest. After such options have fully vested, according to
their original vesting schedule, they are entitled to receive cash and equity
compensation for their service as an Andrx director, in the same amounts as
other non-employee directors ("Outside Directors").

         Board members do not receive any cash retainer for serving on the Board
or its committees. Outside Directors currently receive $5,000 for attendance at
each regularly scheduled Board meeting, $2,500 for attendance at each
non-regularly scheduled, in-person Board meeting or for additional days of
attendance at regularly scheduled Board meetings, and $1,000 for participation
at each telephonic Board and committee meeting. The Lead Director receives an
additional $3,500 for each Board meeting attended in person, an additional
$1,250 for each non-regularly scheduled, in-person Board meeting or additional
days of attendance at regularly scheduled Board meetings, and an additional
$1,000 for each telephonic Board meeting. Committee chairs receive an additional
$500 for participation at each committee meeting.

         Directors are entitled to reimbursement for any costs they incur as a
director and may elect to participate in Andrx's dental plan at their sole cost.

         Outside directors may receive stock options and RSUs at the discretion
of the Compensation Committee. Options are currently granted with an exercise
price at fair market value on the date of the grant and with an expiration date
10 years following the date of the grant. In March of 2003 and 2004,
respectively, the Compensation Committee approved equity compensation grants to
all non-management directors (other than Dr. Sharoky in 2003) on such date that
were to be issued on the date of the annual meeting of stockholders
("stockholders meeting"), which occurred in June of each year. In 2003, such
equity compensation consisted of a grant of 5,000 RSUs (except for the Lead
Director, who received 7,500) and 5,000 stock options. In 2004, such equity
compensation consisted of a grant of 2,500 RSUs and 5,000 stock options. In
addition, Messrs. Rice and Eckert were granted options to purchase 15,000 shares
of Andrx common stock upon joining the Board in April 2003 and Dr. Hahn was
granted 5,000 options on the date of the 2004 stockholders meeting.

<PAGE>

         RSUs represent the right to acquire one share of Andrx common stock,
and currently vest as follows: (i) if the director has at least five years of
total Board service on their date of separation from the Board, the entire grant
vests at separation, (ii) if the director has less than five years of total
Board service on their date of separation from the Board, a prorated portion of
the grant vests, with the pro-ration being equal to the product of the number of
RSUs granted multiplied by a fraction, the numerator of which is the number of
complete months of Board service following the date of grant, and the
denominator of which is 60, and (iii) notwithstanding (i) or (ii) above, no
portion of any grant vests if the separation occurs within 12 months of the date
of grant, and no portion of the Andrx common stock underlying (or representing)
the vested RSU grant may be sold earlier than 90 days after the date of such
director's separation from the Board.

         (1) Mr. Rice served as a non-management director from his appointment
to the board in April 2003 until his appointment as Chief Executive Officer on
February 3, 2004.<PAGE>

EXHIBIT 10.94

                                ANDRX CORPORATION
                      RESTRICTED STOCK UNIT AWARD AGREEMENT

      This Restricted Stock Unit Award Agreement ("Agreement") is entered into
as of _____, ____ between Andrx Corporation, a Delaware corporation (including
any of its subsidiaries or affiliates, the "Company") and __________
("Director"), a member of the Company's Board of Directors (the "Board"),
pursuant to the Company's 2000 Stock Option Plan, as amended and restated (the
"2000 Plan").

      1.    Award of Restricted Stock Units. The Company hereby awards to the
Director as of the date first written above ("Date of Grant"), an award of
__________ restricted stock units (each an "RSU"), with each RSU representing
the right to acquire one share of Andrx Corporation - Andrx Group Common Stock,
par value $0.001 ("Common Stock"), subject to the conditions, restrictions and
limitations set forth below (the "RSU Award"). The Director hereby acknowledges
and accepts such grant and agrees to acquire the RSU Award and the shares of
Common Stock covered thereby upon such terms and subject to such conditions,
restrictions and limitations as provided herein.

      2.    Vesting.

            (a)   Subject to Sections 2(b) and 3, the Director's RSU's shall
vest and become "Vested RSUs" as follows: (i) if the Director has at least five
years of total Board service, such grant shall vest in its entirety on the last
date in which such Director serves as a member of the Board (the "Separation
Date"), (ii) if such Director has less than five years of total Board service on
the Separation Date, then only a prorated portion of the grant shall vest, with
such proration being equal to the product of the number of RSUs granted
multiplied by a fraction, the numerator of which is the number of complete
months of Board service following the date of grant, and the denominator of
which is sixty (60), and (iii) notwithstanding (i) or (ii) above, (A) no portion
of such grant shall vest, if such Separation Date is within 12 months of the
date of grant, and (B) no portion of the Common Stock underlying (or
representing) the Vested RSUs may be sold until at least ninety (90) days after
the Separation Date.

            (b)   Notwithstanding Sections 2(a) and 3, Director shall become
vested in any or all RSUs covered by the RSU Award as of such earlier date or
dates as may be expressly determined by the Company's Board of Directors or its
Compensation Committee (in either case, the "Compensation Committee"), in its
sole discretion.

      3.    Effect of Certain Events Upon Vesting.

            (a)   If Director's service as a member of the Board is terminated
by the Company for Cause (as hereinafter defined), then the Director will
immediately forfeit all right, title and interest in the any RSUs, whether
vested or not.

            (b)   "Cause" shall mean (i) Director's conviction of, or plea of
nolo contendre to, a felony involving a crime of moral turpitude; or (ii)
Director's having been
<PAGE>
found guilty by a court of competent jurisdiction, of commission of any willful
or fraudulent act that is adverse to the interests of Company.

            (c)   If the Director is not a Continuing Director (as hereinafter
defined) following a Change of Control (as hereinafter defined), any unvested
RSUs covered by this Agreement shall immediately vest and become Vested RSUs. As
used herein, "Continuing Director" shall mean (1) any member of the Board, while
such person is a member of the Board, who was a member of the Board prior to the
date of this Agreement, or (2) any person who subsequently becomes a member of
the Board, while such person is a member of the Board (excluding an Acquiring
Person or a representative of any Acquiring Person), if such person's nomination
for election or election to the Board is recommended or approved by a majority
of the Continuing Directors, and a "Change in Control" shall be deemed to have
occurred if (i) any person (including any individual, firm, partnership or other
entity) together with all Affiliates and Associates (as defined under Rule 12b-2
of the General Rules and Regulations promulgated under the Securities Exchange
Act of 1934, as amended (the "Exchange Act") of such person, but excluding (A) a
trustee or other fiduciary holding securities under an employee benefit plan of
Company or any subsidiary of Company, (B) a corporation owned, directly or
indirectly, by the stockholders of Company in substantially the proportions as
their ownership of Company, (C) Company or any subsidiary of Company, or (D)
Director, together with all Affiliates and Associates of Director, is or becomes
the Beneficial Owner (as defined in Rule 13d-3 promulgated under the Exchange
Act), directly or indirectly, of securities of Company representing 40% of more
of the combined voting power of Company's then outstanding securities, such
person being hereinafter referred to as an Acquiring Person; (ii) individuals
who, on the date hereof, are Continuing Directors shall cease for any reason to
constitute a majority of the Board ); or (iii) the stockholders of Company
approve a merger of consolidation of Company with any other corporation, other
than a merger of consolidation that would result in the voting securities of
Company outstanding immediately prior thereto continuing to represent (either by
remaining outstanding or by being converted into voting securities of the
surviving entity) at least 80% of the combined voting power of the voting
securities of Company or such surviving entity outstanding immediately after
such merger or consolidation, or the stockholders or Company approve a plan of
complete liquidation of Company or an agreement for the sale or disposition by
Company of all or substantially all of Company's assets.

      4.    Delivery of Shares.

            (a)   As soon as practicable following an RSU becoming a Vested RSU,
the Company shall deliver to the Director one share of Common Stock for each
Vested RSU.

            (b)   In order to mitigate any loss of deduction under Section
162(m) of the Internal Revenue Code, the Company may elect to defer the
Director's receipt of the shares of Common Stock upon the vesting of any RSUs to
no later than the date 10 days after the Director's employment with the Company
terminates for any reason, so long as the Director agrees to such deferral, with
such agreement not to be unreasonably withheld. The Director is not obligated to
incur any economic loss to effect such mitigation.

                                       2
<PAGE>
      5.    Restrictions on Transfer. The RSU Award granted hereunder to the
Director may not be sold, assigned, transferred, pledged or otherwise
encumbered, whether voluntarily or involuntarily, by operation of law or
otherwise; provided, however, that the RSU Award and/or any Vested RSUs shall be
transferable by the Director, in whole or in part, to members of his immediate
family, to trusts or partnerships formed exclusively for the benefit of the
Director and/or members of his immediate family, or pursuant to a domestic
relations order in settlement of marital property rights. Except as permitted by
the foregoing, no right or benefit under this Agreement shall be subject to
transfer, anticipation, alienation, sale, assignment, pledge, encumbrance or
charge, whether voluntary, involuntary, by operation of law or otherwise, and
any attempt to transfer, anticipate, alienate, sell, assign, pledge, encumber or
charge the same shall be void. No right or benefit hereunder shall in any manner
be liable for or subject to any debts, contracts, liabilities or torts of the
person entitled to such benefits. Any assignment in violation of this Section 5
shall be void.

      6.    Withholding Tax Requirements. If any tax withholding is required,
the Company shall withhold shares of Common Stock at the time Common Stock is
delivered (or otherwise becomes taxable) to the Director, and shall pay only the
statutory minimum withholding amounts to the applicable tax authorities in
accordance therewith.

      7.    Sale and Issuance of Common Stock. The Director agrees that he/she
shall not sell any Common Stock delivered to him/her pursuant to this Agreement
and that the Company shall not be obligated to deliver any shares of Common
Stock if counsel to the Company reasonably determines that such sale or delivery
would violate any applicable law or any rule or regulation of any governmental
authority or any rule or regulation of, or agreement of the Company with, any
securities exchange or association upon which the Common Stock is listed or
quoted. The Company shall be obligated to take all reasonable action in order to
cause the delivery of shares of Common Stock to comply with any such law, rule,
regulation or agreement.

      8.    Limitation of Rights. Nothing contained in this Agreement, and no
action of the Company with respect hereto, shall confer or be construed to
confer on the Director any right to continue as a member of the Board.

      9.    No Interest in Company Assets. The Director shall not have any
interest in any fund or specific asset of the Company by reason of this RSU
Award.

      10.   No Rights as a Stockholder Prior to Delivery. The Director shall not
have any right, title or interest in, or be entitled to vote or receive
distributions in respect of, or otherwise be considered the owner of, any of the
shares of Common Stock covered by the RSU Award, except to the extent that such
shares are Vested RSUs, whether or not delivered to the Director.

      11.   Adjustment. The RSU Award shall be subject to adjustment (including,
without limitation, as to the number of shares of Common Stock covered by the
RSU Award) in the reasonable discretion of the Compensation Committee in such
manner as the Compensation Committee may deem equitable and appropriate if there
shall be any increase or decrease in the number of issued and outstanding shares
of Common Stock through the declaration of a stock dividend or through any
recapitalization resulting in a stock split, combination or exchange of shares
(other than any such exchange or issuance of shares through which shares are
issued to

                                       3
<PAGE>
effect an acquisition of another business or entity or the Company's purchase of
shares to exercise a "call" purchase option). Except as otherwise expressly
provided herein, the issuance by the Company of shares of its capital stock of
any class, or securities convertible into or exchangeable for shares of its
capital stock of any class, either in connection with a direct or unwritten sale
or upon the exercise of rights or warrants to subscribe therefore or purchase
such shares, or upon conversion of obligations of the Company convertible into
such shares or other securities, shall not affect, and no adjustment by reason
thereof shall be made with respect to this RSU Award.

      12.   Miscellaneous Provisions. For purposes of this Agreement, the
following miscellaneous provisions shall be applicable:

            (a)   Company Disclosure. The Director acknowledges and agrees that
the Company, its stockholders and its officers have no duty or obligation to
disclose to the Director any material information regarding the business of the
Company or affecting the value of Common Stock at any time while the Director is
a member of the Board, other than in the normal course of serving as a Director
and at any time following the termination of the Director's service on the
Board.

            (b)   Successors and Assigns. This Agreement shall bind and inure to
the benefit of and be enforceable by the Director, the Company and their
respective permitted successors and assigns (including personal representatives,
heirs and legatees), except that the Director may not assign any rights or
obligations under this Agreement, except to the extent and in the manner
expressly permitted herein.

            (c)   Notices. Any notice under this Agreement to the Company or to
the Director shall be addressed as follows:

            If to the Company:

            8151 Peters Road
            Plantation, FL  33324
            Attention: General Counsel

            If to Director:

            At the address listed on the signature page

            (d)   Severability. If any provision of this Agreement for any
reason should be found by any court of competent jurisdiction to be invalid,
illegal or unenforceable, in whole or in part, such declaration shall not affect
the validity, legality or enforceability of any remaining provision or portion
thereof, which remaining provision or portion thereof shall remain in full force
and effect as if this Agreement had been adopted with the invalid, illegal or
unenforceable provision or portion thereof eliminated.

            (e)   2000 Plan. This Agreement is entered into pursuant to the 2000
Plan, a copy of which has been provided to Director. Director acknowledges that
Director has

                                       4
<PAGE>
received and reviewed the 2000 Plan. Unless specifically set forth in this
Agreement to the contrary, this Agreement shall remain subject to all the
provisions of the 2000 Plan, and in the event there are any inconsistencies by
and among this Agreement and the 2000 Plan, the Director and/or the Company
shall first be bound by the terms of this Agreement, then the 2000 Plan.

            (f)   Amendment. The Company may amend or modify this Agreement at
any time by mutual agreement between the Company and Director (or such other
persons as may then have an interest therein). In addition, by mutual agreement
between the Company and Director (or such other persons as may then have an
interest therein), Director may be granted an award in substitution and exchange
for, and in cancellation of, the RSU Award under any other present or future
plan of the Company or any present or future plan of an entity which (i) is
purchased by the Company, (ii) purchases the Company, or (iii) merges into or
with the Company; provided, however, that such substitution, exchange and/or
cancellation does not increase the accounting charge-to-earnings originally
expensed by the Company with respect to the RSU Award.

            (g)   Headings. The headings, captions and arrangements utilized in
this Agreement shall not be construed to limit or modify the terms or meaning of
this Agreement.

            (h)   Arbitration. Any disputes arising out of or in connection with
this Agreement or any of its provisions, including but not limited to the
alleged breach of the provisions of this Agreement, shall be submitted to and
determined by arbitration conducted in accordance with the Rules of the American
Arbitration Association. The award rendered by the Arbitrator may be entered as
a judgment (with full binding, force and effect) in any court having
jurisdiction thereof. This Agreement shall constitute a written agreement to
submit any such dispute or controversy to arbitration within the meaning of the
Florida Arbitration Code and shall confer jurisdiction on the Courts of the
State of Florida to enforce such agreement to arbitrate and to enter judgment on
an award in accordance with said Florida Arbitration Code.

            (i)   Governing Law. This Agreement shall be governed by and
construed in accordance with the internal laws of the State of Florida. Any
arbitration, lawsuits or other proceedings related to this Agreement or the
transactions herein described shall be commenced and held in Dade or Broward
County, Florida.

            (j)   Determinations by Compensation Committee. All references in
this Agreement to determinations to be made by the Compensation Committee shall
be deemed to include determinations by any person or persons to whom the
Compensation Committee may delegate such authority in accordance with the rules
adopted thereby.

                                       5
<PAGE>
            (k)   Validity of Agreement. This Agreement shall be valid and
binding only if and when it has been duly executed by an officer of the Company
(which may be in facsimile signature) and by Director.

      IN WITNESS WHEREOF, this Restricted Stock Unit Award Agreement has been
executed as of the date first written above.

DIRECTOR:                             ANDRX CORPORATION

By:________________________________   By:____________________________________
Name:______________________________      Thomas P. Rice, Chief Executive Officer

Director Address:
___________________________
___________________________
___________________________

                                       6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00079-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00079-of-00352.parquet"}]]